Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1983 of 5804
-
Could a gentle electric zap heal bedsores faster?
Disease control TerminatedMulticentered randomized controlled study with adaptive design to evaluate if Intermittent Electrical Stimulation (IES) decreases progression and facilitates healing of pressure injuries for patients with, sacral / ischial pressure injuries.
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Brain stimulation tailored to your brain waves could treat depression
Knowledge-focused Recruiting nowNeuropsychiatric disorders are a leading cause of disability worldwide with depressive disorders being one of the most disabling among them. Also, millions of patients do not respond to current medications or psychotherapy, which makes it critical to find an alternative therapy. …
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Vitamin c Mega-Dose tested against deadly sepsis
Disease control CompletedIn this multicenter, randomized, single-blind, placebo-controlled clinical trial. Patients will be randomly assigned to receive Vitamin C or placebo for 4 days or until ICU discharge (whatever come first). The primary outcome is 28-day all-cause mortality.
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New radiation technique aims to ease brain cancer treatment side effects
Symptom relief Recruiting nowThis research is being done to assess the quality of life and symptom burden in participants who receive (normal tissue sparing whole brain radiation therapy (NTS-WBRT). This research study involves: * NTS-WBRT (normal tissue sparing whole brain radiation therapy) * Memantine s…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New hip stem implant tracked for 10 years in 313 patients
Disease control OngoingThe objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
Phase: NA • Sponsor: Stryker Orthopaedics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New app aims to curb HIV in black women
Prevention CompletedBlack women have a significantly higher risk of acquiring HIV compared to their non-Black counterparts. The purpose of this study is to refine and test a mobile HIV Prevention and Reproductive Health app developed specifically for Black women.
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Sickle cell drug oxbryta tracked in real life: what happened?
Disease control TerminatedThis registry is an observational study designed to evaluate the effect of Oxbryta in individuals with SCD in a real-world setting.
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a tumor-zapping procedure also wake up the immune system?
Knowledge-focused CompletedThis cohort study compares immune response induced in two groups of small HCC patients treated by ablation (group1 RFA, group 2 MWA). Patients will benefit for tumoral and non tumoral biopsies prior to treatment and stepped peripheral blood samples juste before ablation and durin…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New study aims to improve knee pain relief by testing better targeting methods
Symptom relief Recruiting nowCooled radiofrequency ablation (cRFA) of the knee geniculate nerves is a promising treatment option for knee osteoarthritis, but has variable efficacy. Fluoroscopy is the typical guidance of choice, but uses bony landmarks to target these nerves which have variable positions arou…
Phase: NA • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New online program aims to help rural dementia caregivers get better sleep
Symptom relief Recruiting nowThe goal of this project evaluate the efficacy of NiteCAPP in improving insomnia in a rural dementia caregiver sample (n of 100 caregiver and PWD dyads). We will measure both the short term (post-treatment) and long term (6 and 12 months) effects of the intervention on CG sleep, …
Phase: NA • Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Home BP checks may prevent dangerous drops during dialysis
Disease control CompletedThe main study will be a two arm 10-month, cross-over randomized controlled trial of 200 participants treated with end-stage-kidney-disease treated with in-center hemodialysis in the Seattle and San Francisco area comparing a strategy of targeting home vs. pre-dialysis systolic b…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could blocking tiny leg arteries relieve knee arthritis pain?
Symptom relief OngoingThe need for exploration of more definitive and cost effective non-arthroplasty treatments of osteoarthritis (OA) has been demonstrated by the orthopedic and health economic research. Embolotherapy of neovessels associated with OA joints has been shown to be promising in patient…
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
PrEP on the spot: HIV prevention delivered at syringe services shows promise
Prevention CompletedThe purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
Phase: PHASE4 • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Can intense exercise help older adults fight muscle loss?
Disease control CompletedSarcopenia is one of the main problems in the elderly population. The concept of disease has evolved, as have its treatment strategies. Among these is high-intensity interval training (HIIT). This approach has been little studied in older adults with sarcopenia, especially in ins…
Phase: NA • Sponsor: University of Extremadura • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Tumor DNA in blood and urine may predict cancer recurrence
Knowledge-focused Recruiting nowIn our study, the ultra-deep sequencing of circulating tumor DNA (ctDNA) and urine tumor DNA (utDNA) were performed to assess whether ctDNA and utDNA can be used as predictive biomarkers for the detection of minimal residual disease (MRD) and early diagnosis of UTUC recurrence, a…
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Can a transplant drug boost heart health in the elderly?
Disease control CompletedThe ability to mount an effective immune response declines with age, leaving the elderly increasingly susceptible to infectious diseases and cancer. Rapamycin, an FDA approved drug to prevent transplant rejection, increases the lifespan and healthspan of mice and ameliorates age-…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a smarter pacemaker save your heart?
Prevention Recruiting nowThe implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Old drug, new hope: could acetazolamide ease tough schizophrenia symptoms?
Symptom relief Recruiting nowThis is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Blood thinner head injury study aims to reduce unnecessary brain scans
Knowledge-focused Recruiting nowThe goal is to derive and a clinical decision rule for safe exclusion of traumatic brain injury without neuroimaging in head-injured ED patients who take anticoagulant medications. The objectives are to: 1. Derive and externally validate a new highly sensitive and maximally spe…
Sponsor: Dr. Kerstin de Wit • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
FDA-Approved ankle replacement under the microscope: will it hold up?
Disease control OngoingThe H3 TAR Prosthesis was approved by FDA (P160036) on June 4, 2019. Continued approval of the premarket approval application (PMA) is contingent upon the submission of periodic reports (Annual Report), required under 21 CFR 814.84. In order to provide continued reasonable assura…
Phase: NA • Sponsor: DT MedTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC